$18.59
1.27% yesterday
Nasdaq, Jun 13, 10:00 pm CET
ISIN
US14167L1035
Symbol
CDNA
Sector
Industry

CareDx, Inc. Stock price

$18.59
+2.46 15.25% 1M
-4.27 18.68% 6M
-2.82 13.17% YTD
+3.98 27.24% 1Y
-13.28 41.67% 5Y
+12.34 197.44% 10Y
+9.54 105.41% 20Y
Nasdaq, Closing price Fri, Jun 13 2025
-0.24 1.27%
ISIN
US14167L1035
Symbol
CDNA
Sector
Industry

Key metrics

Market capitalization $1.04b
Enterprise Value $804.18m
P/E (TTM) P/E ratio 17.54
EV/FCF (TTM) EV/FCF 39.91
EV/Sales (TTM) EV/Sales 2.32
P/S ratio (TTM) P/S ratio 2.99
P/B ratio (TTM) P/B ratio 2.72
Revenue growth (TTM) Revenue growth 25.92%
Revenue (TTM) Revenue $346.42m
EBIT (operating result TTM) EBIT $-42.43m
Free Cash Flow (TTM) Free Cash Flow $20.15m
Cash position $230.92m
EPS (TTM) EPS $1.06
P/E forward negative
P/S forward 2.79
EV/Sales forward 2.17
Short interest 11.93%
Show more

Is CareDx, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,847 stocks worldwide.

CareDx, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a CareDx, Inc. forecast:

4x Buy
50%
4x Hold
50%

Analyst Opinions

8 Analysts have issued a CareDx, Inc. forecast:

Buy
50%
Hold
50%

Financial data from CareDx, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
346 346
26% 26%
100%
- Direct Costs 112 112
10% 10%
32%
234 234
35% 35%
68%
- Selling and Administrative Expenses 202 202
4% 4%
58%
- Research and Development Expense 72 72
5% 5%
21%
-40 -40
59% 59%
-12%
- Depreciation and Amortization 2.52 2.52
1% 1%
1%
EBIT (Operating Income) EBIT -42 -42
57% 57%
-12%
Net Profit 59 59
132% 132%
17%

In millions USD.

Don't miss a Thing! We will send you all news about CareDx, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

CareDx, Inc. Stock News

Positive
Seeking Alpha
about 5 hours ago
CareDx has a unique, comprehensive organ transplant diagnostics portfolio and maintains strong revenue growth, but faces intensifying competition and regulatory risks. Recent legal resolutions and operational improvements have strengthened the investment case, yet the company has never achieved operating profitability, raising concerns. Future growth depends on successful new product launches a...
Neutral
Business Wire
11 days ago
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA), – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced that it has completed the repurchase of $50 million of its common stock representing appr...
Neutral
Business Wire
23 days ago
SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP, a leading stockholder rights law firm, has initiated an investigation into the board members and executive officers of CareDx, Inc. (NASDAQ: CDNA) for potential breaches of fiduciary duties and violations of the federal securities laws. What is Johnson Fistel Investigating? Between April 30, 2020 and February 24, 2022, certain CareDx insiders ca...
More CareDx, Inc. News

Company Profile

CareDx, Inc. operates as a transplant diagnostics company,which discovers, develops, and commercializes diagnostic solutions. Its product includes AlloMap, AlloSure, and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.

Head office United States
CEO John Hanna
Employees 647
Founded 1998
Website www.caredx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today